Clinical Trial Update: Nanoparticle for DSA Removal

View source ↗

Summary

Clinical trial update notes that a University of Zurich-sponsored nanoparticle intended to remove donor-specific antibodies in kidney failure is currently activ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Failure

Snippet

Sponsor: University of Zurich | Conditions: Kidney Failure, Presence of Donor Specific Antibodies | Status: ACTIVE_NOT_RECRUITING